Saturday, 13 September, 2025г.
russian english deutsch french spanish portuguese czech greek georgian chinese japanese korean indonesian turkish thai uzbek

пример: покупка автомобиля в Запорожье

 

Dr. Peeters Discusses the Efficacy and Safety of Panitumumab Versus Cetuximab in Colorectal Cancer

Dr. Peeters Discusses the Efficacy and Safety of Panitumumab Versus Cetuximab in Colorectal CancerУ вашего броузера проблема в совместимости с HTML5
Marc Peeters, MD, PhD, department of oncology, Antwerp University Hospital, Antwerpen, Belgium, discusses the efficacy and safety of panitumumab versus cetuximab as seen in the ASPECCT trial in colorectal cancer (CRC).
Опубликовано: 19-08-2014
Теги: cancer oncology Cetuximab (Drug) Panitumumab Colorectal Cancer (Disease Or Medical Condition) Medicine (Field Of Study) Disease (Cause Of Death)

Похожие видео
Dr. Muro on Results of PaFF-K Study in Colorectal Cancer

Dr. Muro on Results of PaFF-K Study in Colorectal Cancer01:20

Introduction: Bevacizumab Versus Cetuximab in Metastatic Colorectal Cancer

Introduction: Bevacizumab Versus Cetuximab in Metastatic Colorectal Cancer04:28

Dr. Lenz on Breakthrough Designation of Encorafenib, Binimetinib, and Cetuximab in BRAF+ CRC

Dr. Lenz on Breakthrough Designation of Encorafenib, Binimetinib, and Cetuximab in BRAF+ CRC01:13

The Safety and Efficacy of Venetoclax/Obinutuzumab Combo in CLL

The Safety and Efficacy of Venetoclax/Obinutuzumab Combo in CLL03:53

Мой аккаунт

Вход / Log In